Journal article · 2013

Abstract 4373: LRP5: a potential therapeutic target in triple-negative breast cancer.

Sylvie Maubant, Virginie Maire, Bruno M. Tesson, David Gentien, Bérengère Marty-Prouvost, Francisco H. Cruzalegui, Stéphane Depil, Gordon C. Tucker, Sergio Roman‐Roman, Thierry Dubois

Cancer Research, 73(8_Supplement), 4373 · Published 1 April 2013 · DOI 10.1158/1538-7445.am2013-4373

View at the publisherCite this paper

In brief

“Abstract 4373: LRP5: a potential therapeutic target in triple-negative breast cancer.” is a 2013 journal article by Sylvie Maubant and 9 co-authors, published in Cancer Research. OpenAlex counts 1 citations as of 21 November 2026. The publisher's version is not open access, and OpenAlex records no free legal copy.

Citations
1
Most cited in
2020 (1)
References
6
Authors
10

Abstract

Background: Triple-negative breast cancer (TNBC) is associated with poor prognosis, only partial response to chemotherapy and lack of clinically established targeted therapies [1]. A deregulation of the Wnt signaling pathway has been described in breast cancers, particularly in TNBC [2–6]. Low-density lipoprotein receptor-related proteins 5 and 6 (LRP5 and LRP6) serve as Wnt co-receptors for… Read the full abstract at the publisher.

Excerpt. This paper is not open access.

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Maubant, S., Maire, V., Tesson, B. M., Gentien, D., Marty-Prouvost, B., Cruzalegui, F. H., Depil, S., Tucker, G. C., Roman‐Roman, S., & Dubois, T. (2013). Abstract 4373: LRP5: a potential therapeutic target in triple-negative breast cancer. Cancer Research, 73(8_Supplement), 4373. https://doi.org/10.1158/1538-7445.am2013-4373

MLA 9

Maubant, Sylvie, et al. “Abstract 4373: LRP5: a potential therapeutic target in triple-negative breast cancer.” Cancer Research, vol. 73, no. 8_Supplement, 2013, p. 4373. https://doi.org/10.1158/1538-7445.am2013-4373.

Chicago

Maubant, Sylvie, Virginie Maire, Bruno M. Tesson, David Gentien, Bérengère Marty-Prouvost, Francisco H. Cruzalegui, Stéphane Depil, Gordon C. Tucker, Sergio Roman‐Roman, and Thierry Dubois. 2013. “Abstract 4373: LRP5: a potential therapeutic target in triple-negative breast cancer.” Cancer Research 73 (8_Supplement): 4373. https://doi.org/10.1158/1538-7445.am2013-4373.

Harvard

Maubant, S. et al. (2013) ‘Abstract 4373: LRP5: a potential therapeutic target in triple-negative breast cancer.’, Cancer Research, 73(8_Supplement), p. 4373. doi:10.1158/1538-7445.am2013-4373.

IEEE

S. Maubant et al., “Abstract 4373: LRP5: a potential therapeutic target in triple-negative breast cancer.,” Cancer Research, vol. 73, no. 8_Supplement, p. 4373, 2013, doi: 10.1158/1538-7445.am2013-4373.

BibTeX

@article{maubant2013abstract,
  title     = {{Abstract 4373: LRP5: a potential therapeutic target in triple-negative breast cancer.}},
  author    = {Maubant, Sylvie and Maire, Virginie and Tesson, Bruno M. and Gentien, David and Marty-Prouvost, Bérengère and Cruzalegui, Francisco H. and Depil, Stéphane and Tucker, Gordon C. and Roman‐Roman, Sergio and Dubois, Thierry},
  journal   = {Cancer Research},
  year      = {2013},
  volume    = {73},
  number    = {8_Supplement},
  pages     = {4373},
  doi       = {10.1158/1538-7445.am2013-4373},
  url       = {https://doi.org/10.1158/1538-7445.am2013-4373}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Topic and keywords

Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Wnt/β-catenin signaling in development and cancer

  • triple-negative breast cancer
  • LRP5
  • LRP6
  • Wnt signaling
  • Wnt co-receptor
  • therapeutic target
  • apoptosis
  • caspase activation

Work with this paper

Most-cited papers in Biochemistry, Genetics and Molecular Biology

All highly cited Biochemistry, Genetics and Molecular Biology papers

Questions about this paper

How do I cite this paper in APA style?

Maubant, S., Maire, V., Tesson, B. M., Gentien, D., Marty-Prouvost, B., Cruzalegui, F. H., Depil, S., Tucker, G. C., Roman‐Roman, S., & Dubois, T. (2013). Abstract 4373: LRP5: a potential therapeutic target in triple-negative breast cancer. Cancer Research, 73(8_Supplement), 4373. https://doi.org/10.1158/1538-7445.am2013-4373

How many times has this paper been cited?

1 times, according to OpenAlex on 21 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

OpenAlex records no free legal copy. Check your library's access, the authors' pages or a repository, or ask the corresponding author for a copy.

Who wrote this paper?

Sylvie Maubant, Virginie Maire, Bruno M. Tesson, David Gentien, Bérengère Marty-Prouvost, Francisco H. Cruzalegui, Stéphane Depil, Gordon C. Tucker, Sergio Roman‐Roman, Thierry Dubois.

What is the DOI of this paper?

10.1158/1538-7445.am2013-4373, permanently at https://doi.org/10.1158/1538-7445.am2013-4373. Sign in and open it from this page.

Bibliographic data from OpenAlex (CC0), last checked 21 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.